<DOC>
	<DOCNO>NCT00919516</DOCNO>
	<brief_summary>The purpose study evaluate efficacy dual intramuscular intra-arterial autologous bone marrow mononuclear cell implantation treatment patient moderate severe peripheral arterial disease amputation consider viable treatment option . Study Hypothesis : Patients moderate severe peripheral arterial disease receive intramuscular intra-arterial stem cell injection improve ankle brachial index ( ABI ) measurement ; relief rest pain ; ulcer healing , applicable ; absence major limb amputation .</brief_summary>
	<brief_title>Autologous Bone Marrow Mononuclear Cell Implantation Moderate Severe Peripheral Arterial Disease</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Patients least 18 year age . Patients moderate severe limbthreatening PAD , define ankle brachial index ( ABI ) less 0.7 presence nonhealing ischemic ulcer stenosis occlusion two follow low extremity artery : anterior tibial , posterior tibial , peroneal . Patients condition preclude recommendation traditional endovascular open bypass treatment . Patients young 18 year age . Patients eligible undergo traditional endovascular open bypass treatment PAD . Female patient may pregnant . Patients prisoner . Patients mental retardation unable consent participation independently .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Bone marrow transplantation</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Neoangiogenesis</keyword>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>Stem cell therapy</keyword>
</DOC>